FAP-CD40 and PD1-IL2v combination therapy reprograms immunologically cold tumors through de novo intratumoral T cell-dendritic cell clusters.

J Immunother Cancer · 2026 · PMC13223653 · PMID 42208978

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Intratumoral cDC1 numbers showed a decreasing trend within 72 hours of treatment and remained significantly reduced through day 8 compared with untreated controls.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.